Skip to main content
Intercure Ltd. logo

Intercure Ltd. — Investor Relations & Filings

Ticker · INCR ISIN · IL0011063760 LEI · 549300KI5ESXF8F5GP06 TA Manufacturing
Open in API
Filings indexed 334 across all filing types
Latest filing 2022-03-01 Report Publication Anno…
Country IL Israel
Listing TA INCR

About Intercure Ltd.

https://www.intercure.co

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Recent filings

Filing Released Lang Actions
Immediate Report
Report Publication Announcement Classification · 1% confidence The document is an 'Amended report' broadcast via the MAGNA system, referencing the Israel Securities Authority and the Tel Aviv Stock Exchange. It explicitly states it is an 'Immediate Report' under Regulation 4 of the Securities Regulations for Foreign Corporations. Crucially, the text ends with 'Attached hereto is a report on* *intercure_v2_isa.pdf*'. Since the document itself is very short (2058 characters) and its primary function is to announce the publication of an attached PDF report, it fits the definition of a Report Publication Announcement (RPA) rather than the report content itself (like 10-K or IR).
2022-03-01 English
InterCure Announces Partnership with Altman Health
Environmental & Social Information Classification · 1% confidence The document is a press release dated March 1, 2022, announcing a partnership between InterCure Ltd. and Altman Health Ltd. regarding the Israeli CBD market. While it contains a section titled "Update Regarding 2021 Financial Statements" which mentions filing audited financial statements (10-K/AR content) by March 31, 2022, the primary content is a business development announcement (partnership). This type of announcement, which details strategic agreements and market positioning, is typically classified as a general corporate update or news release. Since there is no specific category for general business development announcements that aren't M&A (TAR) or financing (CAP), and it is not a transcript (CT), earnings release (ER), or a formal regulatory filing like 10-K or IR, the most appropriate fallback category is Regulatory Filings (RNS) for miscellaneous corporate news, although it strongly resembles an Earnings Release (ER) precursor or a general Investor Presentation (IP) snippet, but it lacks the formal structure of those. Given the content is a major business announcement, and not a formal report or a specific transaction notice, RNS is the best fit as a general regulatory/corporate announcement.
2022-03-01 English
InterCure Announces Partnership with Altman Health
Regulatory Filings Classification · 1% confidence The document is very short (1792 characters) and explicitly states, "Attached hereto is a report on *altman_isa.pdf*". This structure indicates that the document itself is not the full report but rather an announcement that another document (likely a regulatory filing or report) is attached or being published. The filing references the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE) and uses the header "Immediate Report Regulation 4 of the Securities Regulations...", suggesting a mandatory disclosure. Since it is an announcement of a report rather than the report itself, and it is a regulatory disclosure that doesn't fit specific categories like ER, 10-K, or IR, the most appropriate classification based on the 'MENU VS MEAL' rule and the general nature of the filing is Report Publication Announcement (RPA) or Regulatory Filing (RNS). Given the explicit mention of attaching a report, RPA is slightly more precise than the general RNS fallback, although RNS is also plausible for mandatory regulatory disclosures. I will select RPA as it directly addresses the action of publishing/attaching a report.
2022-03-01 English
InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer “Better”
M&A Activity Classification · 1% confidence The document is a press release dated February 16, 2022, announcing that InterCure Ltd. has signed a definitive agreement to acquire another company, Better. The text details transaction highlights, purchase price, closing conditions, and includes forward-looking statements typical of corporate transaction announcements. This type of announcement, detailing a merger or acquisition proposal, aligns directly with the definition for M&A Activity (TAR). It is not a standard periodic report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2022-02-16 English
InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer “Better”
Report Publication Announcement Classification · 1% confidence The document is very short (1792 characters) and explicitly states, "Attached hereto is a report on *Better_isa.pdf*". This structure—a brief announcement referencing an attached or linked full report—strongly indicates that this filing is an announcement about the publication of another document, rather than the report itself. The filing references the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE) and uses the header "Immediate Report Regulation 4...", suggesting a mandatory regulatory disclosure. Since it is an announcement of a report's availability and does not fit the specific definitions for ER, 10-K, IR, etc., the most appropriate classification based on Rule 2 (The 'Menu vs Meal' Rule) is Report Publication Announcement (RPA).
2022-02-16 English
Foreign Filer Report 2022
Foreign Filer Report
2022-02-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.